Evidence map›Paper›PMID 41062826›Full record

ArticleNature methods2025

Automated classification of cellular expression in multiplexed imaging data with Nimbus.

Josef Lorenz Rumberger, Noah F Greenwald, Jolene S Ranek, Potchara Boonrat, Cameron Walker, Jannik Franzen, Sricharan Reddy Varra, Alex Kong, Cameron Sowers, Candace C Liu and 11 more

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Josef Lorenz Rumberger *Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-7225-7011
Noah F Greenwald *Department of Pathology, Stanford University, Stanford, CA, USA. nfgreen@stanford.edu.ORCID http://orcid.org/0000-0002-7836-4379
Jolene S RanekDepartment of Pathology, Stanford University, Stanford, CA, USA.
Potchara BoonratDepartment of Pathology, Stanford University, Stanford, CA, USA.
Cameron WalkerDepartment of Pathology, Stanford University, Stanford, CA, USA.
Jannik FranzenMax-Delbruck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Sricharan Reddy VarraDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0009-0000-5757-6818
Alex KongDepartment of Pathology, Stanford University, Stanford, CA, USA.
Cameron SowersDepartment of Pathology, Stanford University, Stanford, CA, USA.
Candace C LiuDepartment of Pathology, Stanford University, Stanford, CA, USA.
Inna AverbukhDepartment of Pathology, Stanford University, Stanford, CA, USA.
Hadeesha PiyadasaDepartment of Pathology, Stanford University, Stanford, CA, USA.
Rami VanguriDivision of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Iris NederlofDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-7608-6515
Xuefei Julie WangDivision of Biology and Biological Engineering, Caltech, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-9327-9543
David Van ValenDivision of Biology and Biological Engineering, Caltech, Pasadena, CA, USA.ORCID http://orcid.org/0000-0001-7534-7621
Marleen KokDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sean C BendallDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1341-2453
Travis J HollmannDivision of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Dagmar KainmuellerMax-Delbruck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Michael AngeloDepartment of Pathology, Stanford University, Stanford, CA, USA. mangelo0@stanford.edu.ORCID http://orcid.org/0000-0003-1531-5067

Funding

The Bone Marrow Multi-modal Imaging CoreU54HL165445 · NHLBI · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2022 to 2025
$5.9M
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers DiseaseR01AG057915 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$4.5M
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam ImagingR01AG056287 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$2.6M
Predictive signatures in breast cancer using multiplexed ion beam imagingDP5OD019822 · OD · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL · 2014 to 2018
$2.0M
A robust platform for multiplexed, subcellular proteomic imaging in human tissueUH3CA246633 · NCI · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2019 to 2021
$1.8M
Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approachR01AI189963 · NIAID · STANFORD UNIVERSITY · PI Robert michael Angelo, Prasanna Jagannathan · 2025 to 2026
$1.6M
NCI NIH HHS UH3 CA246633NHLBI NIH HHS U54 HL165445NIAID NIH HHS R01 AI189963NIA NIH HHS R01 AG056287NIA NIH HHS R01 AG057915NIH HHS DP5 OD019822U.S. Department of Health & Human Services | National Institutes of Health (NIH) 5U54CA20997105U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA264307
6 · The paper itself

Abstract

Multiplexed imaging offers a powerful approach to characterize the spatial topography of tissues in both health and disease. To analyze such data, the specific combination of markers that are present in each cell must be enumerated to enable accurate phenotyping, a process that often relies on unsupervised clustering. We constructed the Pan-Multiplex (Pan-M) dataset containing 197 million distinct annotations of marker expression across 15 different cell types. We used Pan-M to create Nimbus, a deep learning model to predict marker positivity from multiplexed image data. Nimbus is a pretrained model that uses the underlying images to classify marker expression of individual cells as positive or negative across distinct cell types, from different tissues, acquired using different microscope platforms, without requiring any retraining. We demonstrate that Nimbus predictions capture the underlying staining patterns of the full diversity of markers present in Pan-M, and that Nimbus matches or exceeds the accuracy of previous approaches that must be retrained on each dataset. We then show how Nimbus predictions can be integrated with downstream clustering algorithms to robustly identify cell subtypes in image data. We have open-sourced Nimbus and Pan-M to enable community use at https://github.com/angelolab/Nimbus-Inference .

Indexed as

Image Processing, Computer-AssistedSoftwareAlgorithmsAnimalsBiomarkersCluster AnalysisDeep LearningHumansBiomarkers

Identifiers

PMID41062826
PMCPMC13317004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.